Mechanisms of antibiotics influence on intestine, role of Enterol in the prophylaxis and treatment of antibiotic-associated diarrhea in children


Cite item

Full Text

Abstract

Mechanisms of antibiotics influence on intestine, role of Enterol in the prophylaxis and treatment of antibiotic-associated diarrhea in children

About the authors

E A Kornienko

E Kornienko

References

  1. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992;15:573-81.
  2. Beaugerie L, Flahault A, Barbut F, et al. Antibiotic-associated diarrhea and Clostridium difficile in the community. Aliment Pharmacol Ther 2003;17:905-12.
  3. Bouhnik Y, Rambaut JC, Buts JP, ets. Microflora and diarrhoea: antibiotic-associated diarrhoea. Gut Microflora. 2006;181-197.
  4. Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2,462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001;47:43-50.
  5. McFarland LV, Brandmarker SA, Guandalini S. Pediatric Clostridium difficile: a phantom menace or clinical reality? J Pediatr Gasroenterol Nutr 2000;31:220-31.
  6. Delmee M, Verellen G, Avesani V, et al. Clostridium difficile in neonates: serogrouping and epidemiology. Eur J Pediatr 1988;147:36-40.
  7. Larson HE, Barclay FE, Honour P, et al. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982;146:727-33.
  8. Ferroni A, Merckx J, Ancelle T, et al. Nosocomial outbreak of Clostridium difficile diarrhea in a pediatric service. Eur J Clin Microbiol nfect Dis 1997;16:928-33.
  9. Rambaud JC, LaMont JT, Buts JP. The clinical significance of Clostridium difficile infections in infants and children. 1996;29-36.
  10. Benoit R, Danquechin DE, Loulergue J, et al. Diarroea post-antibiotique : role de Klebsiella oxytoca. Gasroenterol Clin Biol 1992;16:860-64.
  11. Rambaud JC, LaMont JT, Lamont JT. Recent advances in the structures and function of Clostridium difficile toxins. 1996;72-86.
  12. Price AB. Pseudomembranous colitis. 2005;15-172.
  13. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associatied diarrhea: a review. Arch Intern Med 2000;161(525):5-33.
  14. Rambaud JC, Ducluzeau R, Cooperstock M. Clostridium difficile in infants and children. 1990;81-94.
  15. Harris PR, Figueroa-Colon R. Rectal prolapse in children associated with Clostridium difficile infection. Pediatr Infect Dis J 1995;14:78-80.
  16. Garlani MJ, Murray JC, Morad AB, et al. Chronic osteomyelitis caused by Clostridium difficile in an adolescent with sickle cell disease. Pediatr Infect Dis J 1996;15:1054-56.
  17. Thomas DFM, Fernie DS, Bayston R, et al. Clostridial toxins in neonatal necrotising enterocolitis. Arch Dis Child 1984;59:270-83.
  18. Cetina-Sauri G, Sierra Basto G. Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Annales de Pediatrie 1994;41(6):397-400.
  19. Castaneda C, Garcia E, Santa Cruz M, et al. Effects of Saccharomyces boulardii in children with chronic diarrhea, especially cases due to giardiasis. Revista Mexicana de Puericultura y Pediatria 1995;2:12.
  20. Castagliuolo I, LaMont JT, Nikulasson ST, et al. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infection and Immunity 1996;12:5225-32.
  21. Gedek BR. Adherence of E.coli serogroup O-157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999;42(4):261-64.
  22. Cherucka D, Dahan S, Mograbi B, et al. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infection and Immunity 2000;68:5998-6004.
  23. Dahan S, Dalmasso G, Imbert V, et al. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infection and Immunity 2003;72(2):766-73.
  24. Buts JP, Bernasconi P, Van Craymest MP, et al. Response of human and rat small intestinal mucosa to oraladministration of Saccharomyces boulardii. Pediatric Research 1986;20:192-96.
  25. Sougiolzis S. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kB-mediated IL-8 gene expression. Biochem Biophys Res Commun 2006;2:23.
  26. Girard-Pipau F, Pompei A, Schneider S, et al. Intestinal microflora, short chain and cellular fatty acids, influence of a probiotic Saccharomyces boulardii. Microb Ecolog in Health Dis 2002;14:220-27.
  27. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii for Clostridium difficile- associated entheropathies in infants. J Pediatr Gastroenterol Nutr 1993;16:419-25.
  28. Costalos C, Skouteri V, Gounaris A, et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003;11:89-96.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies